CDC study reveals critical gaps in hantavirus detection across the U.S. due to inconsistent testing standards

Pli­ant Ther­a­peu­tics un­veiled more ef­fi­ca­cy da­ta from a small mid-stage tri­al of its lead can­di­date in id­io­path­ic pul­monary fi­bro­sis, which shows that its oral drug

US drug reg­u­la­tors have turned down Ipsen’s ef­fort to slow down gener­ic com­pe­ti­tion for its block­buster drug So­mat­u­line De­pot, which is used to slow the